Search

Your search keyword '"Schadt, Eric"' showing total 2,397 results

Search Constraints

Start Over You searched for: Author "Schadt, Eric" Remove constraint Author: "Schadt, Eric"
2,397 results on '"Schadt, Eric"'

Search Results

301. Obesity and genetics regulate microRNAs in islets, liver, and adipose of diabetic mice

303. Biopsy and blood-based molecular biomarker of inflammation in IBD

306. Molecular networks as sensors and drivers of common human diseases

307. Genetic variants associated with inherited cardiovascular disorders among 13,131 asymptomatic older adults of European descent

308. Effect of APOE and a polygenic risk score on incident dementia and cognitive decline in a healthy older population

310. Extracting longitudinal anticancer treatments at scale using deep natural language processing and temporal reasoning.

311. Comparative efficacy of docetaxel versus novel hormonal agent in de novo metastatic hormone-sensitive prostate cancer: Real-world data curated by deidentified chart abstraction.

313. Analyzing treatment patterns and time to the next treatment in chronic lymphocytic leukemia real-world data using automated temporal phenotyping.

314. Phenotyping of clinical trial eligibility text from cancer studies into computable criteria in electronic health records.

315. Analysis of Real-World Data to Investigate the Impact of Race and Ethnicity on Response to Programmed Cell Death-1 and Programmed Cell Death-Ligand 1 Inhibitors in Advanced Non-Small Cell Lung Cancers

317. A composite biomarker of neutrophil-lymphocyte ratio and hemoglobin level correlates with clinical response to PD-1 and PD-L1 inhibitors in advanced non-small cell lung cancers

318. Haploinsufficiency of POU4F1 causes an ataxia syndrome with hypotonia and intention tremor

319. Integrative Network Analysis of Early-Stage Lung Adenocarcinoma Identifies Aurora Kinase Inhibition as Interceptor of Invasion and Progression

320. COVID-19 outcomes among hospitalized men with or without exposure to alpha-1-adrenergic receptor blocking agents

321. Myeloid Cell–associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA Sequencing

322. Discovery and fine-mapping of height loci via high-density imputation of GWASs in individuals of African ancestry

323. Proteogenomic and metabolomic characterization of human glioblastoma

325. Variations in DNA elucidate molecular networks that cause disease

326. Genetics of gene expression and its effect on disease

329. Additional file 1 of A reference profile-free deconvolution method to infer cancer cell-intrinsic subtypes and tumor-type-specific stromal profiles

330. Association of Body Mass Index with DNA Methylation and Gene Expression in Blood Cells and Relations to Cardiometabolic Disease: A Mendelian Randomization Approach

333. Pharmacogenetics of metformin response: a step in the path toward personalized medicine

334. Integrative Approach to Sporadic Alzheimer’s Disease: Deficiency of driver Tyrobp/Dap12 in cerebral Aβ amyloidosis mouse normalizes clinical phenotype and complement subnetwork molecular pathology without reducing Aβ burden

335. Genomic analyses implicate noncoding de novo variants in congenital heart disease.

336. Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies

339. List of Contributors

340. Improving Pre-eclampsia Risk Prediction by Modeling Individualized Pregnancy Trajectories Derived from Routinely Collected Electronic Medical Record Data

341. Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer

342. Bayesian Model Infers Drug Repurposing Candidates for Treatment of COVID-19

343. A Drosophila platform identifies a novel, personalized therapy for a patient with adenoid cystic carcinoma

345. Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma

346. Protective lipid-lowering genetic variants in healthy older individuals without coronary heart disease

347. Polygenic risk score for alcohol drinking behavior improves prediction of inflammatory bowel disease risk

348. Abstract PS7-04: Population-based estimates of breast cancer risk for germline pathogenic variants identified by gene-panel testing: An Australian perspective

349. A Molecular network approach reveals shared cellular and molecular signatures between chronic fatigue syndrome and other fatiguing illnesses

350. An integrative multiomic network model links lipid metabolism to glucose regulation in coronary artery disease

Catalog

Books, media, physical & digital resources